The association of preoperative thrombocytosis with prognostic factors in malign ovarian tumor

European Journal of Gynaecological Oncology

Volumn 31, Issue 5, 2010, Pages 514-516

  Kuyumcuoglu, U ^a   Guzel, A I ^a   Celik, Y ^a   Erdemoglu M ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Ovarian cancer; Prognosis; Thrombocytosis

Indexed keywords

BLEOMYCIN; CA 125 ANTIGEN; CARBOPLATIN; ETOPOSIDE; PACLITAXEL;

ABDOMINAL SURGERY; ADULT; APPENDECTOMY; ARTICLE; ASCITES; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OMENTECTOMY; OVARY CANCER; PREOPERATIVE PERIOD; PROGNOSIS; SALPINGOOOPHORECTOMY; THROMBOCYTOSIS;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; THROMBOCYTOSIS;

EID: 78549246204     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Tamussino K.P., Gucer P., Reich O., Moser F., Petru E., Scholz H.S.: "Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma". Int. J. Gynecol. Cancer, 2001, 11, 236.
2. Hernandez E., Donohue K.A., Anderson L.L., Heller P.B., Stehman F.B.: "The significance of thrombocytosis in cases with locally advanced cervical carcinoma: a Gynecologic Oncology Group study". Gynecol. Oncol., 2000, 78, 137.
3. Priebe Z., Watrowski R., Bembnista M., Rokowska A., Wlosiinska J.: "Correlation between platelet count and CA-125 in ovarian cancer". Ginekol. Pol., 76, 187.
4. Li A.J., Madden A.C., Cass I., Leuchter RS, Lagasse L.D., Karian B.Y.: "The prognostic significance of thrombocytosis in epithelial ovarian carcinoma". Gynecol. Oncol., 2004, 92, 211.
5. Menczer J., Schejter E., Geva D., Ginath S.: "Ovarian carcinoma associated thrombocytosis: correlation with prognostic factors and with survival". Eur. J. Gynaecol. Oncol., 1998, 12, 82.
6. Hoffman R.: "Regulation of megakaryocytopoiesis". Blood., 1989, 74, 1196.
7. Amoletti J.P., Albo D., Granick M.S., Solomon M.P., Castiglioni A., Rothman V.L.: "Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells". Cancer, 1995, 76, 998.
8. Dabrow M.B., Francesco M.R., McBrearty F.X., Caradonna S.: "The effeect of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium". Gynecol. Oncol., 1998, 71, 29.
9. Qian X., Tuszynski G.P.: "Expression of thrombospondin-1 in cancer: a role in tumor progression". Proc. Soc. Exp. Biol. Med., 1996, 212, 199.
10. Levin J., Conley C.L.: "Thrombocytosis associated with malignant disease". Arch. Int. Med., 1964, 114, 497.
11. Zeimet A.G., Marth C., Muller-Holzner E., Daxenbichler G., Dapunt O.: "Significance of thrombocytosis in cases with epithelial ovarian cancer". Am. J. Obstet. Gynecol., 1994, 170, 549.
12. Li A.J., Madden A.C., Cass I., Leuchter R.S., Lagasse L.D., Karlan B.Y.: "The prognostic significance of thrombocytosis in epithelial ovarian carcinoma". Gynecol. Oncol., 2004, 92, 211.
13. Menczer J., Schejter E., Geva D., Ginath S., Zakut H.: "Ovarian carcinoma associated thrombocytosis: correlation with prognostic factors and with survival". Eur. J. Gynaecol. Oncol., 1998, 12, 82.
14. Gungor T., Kanat-Pektas M., Sucak A., Mollamahmutoglu L.: "The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors". Arch. Gynecol. Obstet., 2009, 279, 53.